Good Life Advisors’s Zimmer Biomet ZBH Stock Holding History

Good Life Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,946	Closed	-$1.45M	–	453
2023 Q3	$1.45M	Buy	+12,946	New	+$1.64M	0.17%	118

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Good Life Advisors's ZBH Position: Q4 2023 in Review

Good Life Advisors sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 12,946 shares — an estimated $1.45M sold.

Good Life Advisors first reported a position in ZBH in Q3 2023 and held it in 1 quarter. The position peaked at $1.45M in Q3 2023. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

Good Life Advisors reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
Good Life Advisors sold 12,946 Zimmer Biomet shares in Q4 2023, an estimated $1.45M.
Good Life Advisors first reported a position in Zimmer Biomet in Q3 2023 and held it in 1 quarter.
Good Life Advisors's Zimmer Biomet position peaked at $1.45M in Q3 2023.
1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on Good Life Advisors's 13F filing for Q4 2023, filed 18 Jan 2024.